Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis

NCT02780323 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: CELBESTA®
DRUG: CELEBREX®
DRUG: CELEBREX® placebo
DRUG: CELBESTA® placebo

Sponsor

Dong-A ST Co., Ltd.